These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
267 related articles for article (PubMed ID: 11655169)
61. The Food and Drug Administration's role in the protection of human subjects. Nightingale SL IRB; 1983; 5(1):6-9. PubMed ID: 11649511 [No Abstract] [Full Text] [Related]
62. A noninstitutional review board comes of age. Herman SS IRB; 1989; 11(2):1-6. PubMed ID: 11650173 [No Abstract] [Full Text] [Related]
63. The paradoxical case of payment as benefit to research subjects. Macklin R IRB; 1989; 11(6):1-3. PubMed ID: 11650284 [No Abstract] [Full Text] [Related]
64. IRB review of adverse events in investigational drug studies. Prentice ED; Gordon B IRB; 1997; 19(6):1-4. PubMed ID: 11656910 [No Abstract] [Full Text] [Related]
65. The changing clinical trials scene: the role of the IRB. Mitchell SC; Steingrub J IRB; 1988; 10(4):1-5. PubMed ID: 11650078 [No Abstract] [Full Text] [Related]
66. Gene therapy and AIDS: a constitutional politics report. Carmen IH Politics Life Sci; 1993 Aug; 12(2):279-80. PubMed ID: 11654725 [No Abstract] [Full Text] [Related]
67. V.A. hospital is told to halt all research. Hilts PJ N Y Times Web; 1999 Mar; ():A25. PubMed ID: 11648101 [No Abstract] [Full Text] [Related]
68. Protection of human subjects. United States Code Fed Regul Shipping; 1982 Oct; Part 46, Sections 46.101 to 46.306():. PubMed ID: 11660819 [No Abstract] [Full Text] [Related]
69. Multicenter trials and subject eligibility: should local IRBs play a role? Freedman B IRB; 1994; 16(1-2):1-6. PubMed ID: 11652320 [No Abstract] [Full Text] [Related]
70. The case of two devices: disclosure to subjects following Phase IV ("post-marketing") research. Anderson JR; Jameton A; Reitemeier PJ; Prentice E IRB; 1995; 17(3):6-9. PubMed ID: 11654269 [No Abstract] [Full Text] [Related]
71. Law and medical experimentation: of embryos, children and others with limited legal capacity. Dworkin G Monash Univ Law Rev; 1987 Dec; 13(4):189-208. PubMed ID: 11659196 [No Abstract] [Full Text] [Related]
72. Broader oversight for research on humans? Kaiser J Science; 1997 Jan; 275(5300):605. PubMed ID: 11644893 [No Abstract] [Full Text] [Related]
73. Informed consent to participate in research: Part II. Levine RJ Bioethics Dig; 1977 Apr; 1(12):1-16. PubMed ID: 11664810 [No Abstract] [Full Text] [Related]
75. Research subject loses case against physician, IRB, and hospital. Maloney DM Hum Res Rep; 1995 Feb; 10(2):4-5. PubMed ID: 11654160 [No Abstract] [Full Text] [Related]
76. Human experimentation. Protecting patient autonomy through informed consent. Tuthill KA J Leg Med; 1997 Jun; 18(2):221-50. PubMed ID: 9230568 [No Abstract] [Full Text] [Related]
77. Fears mount for gene scrutiny as watchdog faces axe. Kiernan V New Sci; 1996 Jun; 150(2033):10. PubMed ID: 11656540 [No Abstract] [Full Text] [Related]
80. Human experimentation: the review process in practice. Cowan DH Case West Reserve Law Rev; 1975; 25(3):533-64. PubMed ID: 11661165 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]